About: Oncology clinical trials during the COVID-19 outbreak: lessons learnt during the crisis and future opportunities

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Oncology clinical trials during the COVID-19 outbreak: lessons learnt during the crisis and future opportunities Goto Sponge NotDistinct Permalink

An Entity of Type : schema:ScholarlyArticle, within Data Space : wasabi.inria.fr associated with source document(s)

Attributes	Values
type	Academic Article research paper schema:ScholarlyArticle
isDefinedBy	Covid-on-the-Web dataset
has title	Oncology clinical trials during the COVID-19 outbreak: lessons learnt during the crisis and future opportunities
Creator	Uk, Arkenau, Hendrik-Tobias Arkenau, Tobias Arkenau@hcahealthcare, Fontana, Elisa Fontana@hcahealthcare, Elisa Uk, Hendrik-Tobias
Source	Elsevier; Medline; PMC
abstract	The COVID-19 pandemic affected many activities in the healthcare system including oncology drug development. Clinical trial recruitment was temporary halted in many centres to reduce patients and healthcare workers’ potential exposure to the virus. Conversely, to continue offering treatments for patients already on effective therapies, multiple actions were timely put in place, resulting in simplification of trial-related procedures for patients and clinicians’ best interest, reduction of the operational burden and effective communication. Here, we suggest maintaining effective measures for future trial simplification and to expedite drug development.
has issue date	2020-06-10(xsd:dateTime)
bibo:doi	10.1016/j.ctrv.2020.102047
bibo:pmid	32544543
has license	no-cc
sha1sum (hex)	972c35cd309f7c8190a9e20f895d1c9095982cb8
schema:url	https://doi.org/10.1016/j.ctrv.2020.102047
resource representing a document's title	Oncology clinical trials during the COVID-19 outbreak: lessons learnt during the crisis and future opportunities
has PubMed Central identifier	PMC7286270
has PubMed identifier	32544543
schema:publication	Cancer Treat Rev
resource representing a document's body	covid:972c35cd309f7c8190a9e20f895d1c9095982cb8#body_text
is schema:about of	named entity 'clinical trials' named entity 'COVID-19' covid:arg/972c35cd309f7c8190a9e20f895d1c9095982cb8 named entity 'Contract Research Organisations' named entity 'COVID-19' named entity 'GCP' named entity 'CROs' named entity 'opportunities' named entity 'Cancer' named entity 'Treatment' named entity 'Oncology' named entity 'clinical trials' named entity 'oncology' named entity 'safety monitoring' named entity 'blood tests' named entity 'CROs' named entity 'unnecessary procedures' named entity 'COVID-19 pandemic' named entity 'healthcare providers' named entity 'Europe' named entity 'oncology' named entity 'status quo' named entity 'patient safety' named entity 'clinical trial' named entity 'research teams' named entity 'Telemedicine' named entity 'GCP' named entity 'exposure to the virus' named entity 'clinical trial' named entity 'intravenous drugs' named entity 'COVID-19' named entity 'COVID-19 outbreak' named entity 'Declaration of Helsinki' named entity 'Quality of life' named entity 'mechanism of action' named entity 'drug development' named entity 'comorbidities' named entity 'drug development' named entity 'CROs' named entity 'clinical trial' named entity 'COVID-19' named entity 'Asia' named entity 'oncology' named entity 'R&D' named entity 'exposure to the virus' named entity 'biotech' named entity 'patient safety' named entity 'drug development' named entity 'patient reported outcome measures' named entity 'COVID-19 pandemic' named entity 'drug-related' named entity '1, 2' named entity 'telemedicine' named entity 'oncology' named entity 'blood tests' named entity 'Wuhan' named entity 'China' named entity 'clinical trial' named entity 'medical monitoring' named entity 'medical monitors' named entity 'NIHR' named entity 'oncology' named entity 'Good Clinical Practice' named entity 'COVID-19 outbreak' named entity 'ONCOLOGY' named entity 'lessons learnt' named entity 'CLINICAL TRIALS' named entity 'FUTURE' named entity 'Oncology' named entity 'Cancer' named entity 'Treatment' named entity 'CRISIS' named entity 'future' named entity 'OUTBREAK' named entity 'APPEAR'

Faceted Search & Find service v1.13.91 as of Mar 24 2020

Alternative Linked Data Documents: Sponger | ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3229 as of Jul 10 2020, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (94 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software